SVB’s collapse is a reminder of how far IP finance still has to travel
Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it
Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it
The takeover of the biopharma innovator is the largest pharma sector deal since 2019
New rules on transfer pricing drawn up by the OECD, which could be adopted by authorities in well over 100 countries, are set to have a major impact on how businesses manage their intangible assets
Data platform changes at the USPTO may mean transactions are being recorded more slowly than usual, says AST
08 December 2022
Imago BioSciences buyout is intended to diversify the company’s revenue streams
28 November 2022
Selling revenue streams is an increasingly important way of monetising pharma innovations
16 November 2022
An over-arching theme during an IAM event was the key importance of relationships, trust and empathy between parties when deals are getting done
11 November 2022
Strategic review of the licensing business nears a year in motion with no news on potential divestment announced
10 November 2022
Behzad Khosrowshahi, CEO of DRI Healthcare Trust, looks at recent deals the firm has done, explains what makes a transaction attractive and how to get one over the line
04 November 2022
As the sovereign patent fund closes down, CEO Didier Patry shares his thoughts with IAM readers on the organisation’s work over the past decade
03 November 2022
A broad range of subjects and talking points - including a plenary address from JPO Commissioner Koichi Hamano - kept the 400+ delegates engaged as the event got underway in Tokyo
01 November 2022
The series of missteps and errors in the Canadian company’s struggling patent portfolio sale offers a cautionary tale to any IP owner emulating this in future
29 October 2022
The company’s high value was produced by a series of innovative patent transactions
27 October 2022
Unlock unlimited access to all IAM content